FDA OKs Roche HIV-1/HIV-2 combo test

The FDA approves Roche’s (OTCQX:RHHBY) cobas HIV-1/HIV-2 Qualitative Test for the qualitative detection and differentiation of HIV-1 and HIV-2 RNA in serum or plasma. The nucleic acid amplification assay is performed on the fully automated cobas 6800/8800 systems in the U.S.

https://seekingalpha.com/news/3610344-fda-oks-roche-hivminus-1-hivminus-2-combo-test